Malaria is caused by the infection and proliferation of parasites from the genus Plasmodium in red blood cells (RBCs). A free Plasmodium parasite, or merozoite, released from an infected RBC must invade another RBC host cell to sustain a blood-stage infection. Here, we review recent advances on RBC invasion by Plasmodium merozoites, focusing on specific molecular interactions between host and parasite.
INTRODUCTION
To ensure their survival, malaria parasites use sophisticated mechanisms to engage and infiltrate host cells. In a human host, following a bite from an infected mosquito and an initial phase of infection and replication in liver cells, parasites enter the bloodstream where they may proliferate indefinitely in red blood cells (RBCs). For RBC infection, a parasite must invade the host cell, a process requiring attachment to the plasma membrane surface followed by entry into the cytoplasmic space. The clinical symptoms and pathogenicity of malaria are caused entirely by this blood-stage of infection, wherein parasites proliferate and persist through alternating cycles of RBC invasion and asexual replication within the RBC.
Plasmodium falciparum is the most virulent malaria species responsible for the greatest number of fatalities (0.5 million per year globally), primarily among children in sub-Saharan Africa. P. vivax continues to be responsible for a substantial burden of disease, and an increasing incidence of malaria caused by P. knowlesi in Southeast Asia is an emerging matter of public health. P. ovale and P. malariae, though less well studied, also cause human malaria.
distinctive cell biological features of merozoites are their micronemes and rhoptries, organelles located near their smaller apical ends. These organelles secrete factors for invasion either onto the parasite surface or into the RBC. Our modern understanding of RBC invasion by merozoites ( Fig. 1 ) is based primarily on microscopic studies to define the kinetic and morphological features [1] [2] [3] [4] [5] [6] , and molecular studies to establish the functions of specific protein factors [7-9,10 && ,11] . We refer the reader to excellent reviews that provide a detailed account of RBC invasion by Plasmodium merozoites [7, 12] .
The primary purpose of this review is to highlight significant, recent cellular and molecular advances in research of RBC invasion by Plasmodium merozoites. We also discuss progress in vaccine efforts targeting RBC invasion.
PRIMARY PARASITE-RBC ENCOUNTERS: FAST BUT NOT THAT LOOSE?
Live video microscopy has shown that free merozoites of both P. knowlesi and P. falciparum can attach to the RBC membrane at any point along the parasite plasma membrane surface. Upon RBC encounter, merozoites appear to 'roll' on the RBC surface and dissociate with some frequency [1, 2] ; these primary interactions have been thought to be weak. The use of optical tweezers to study P. falciparum merozoite-RBC interactions for the first time directly addresses the strength of cellular attachment, providing evidence that nonoriented adhesion is in fact similarly strong (35-40 pN0) to oriented, stable attachment [13 & ]. These results may suggest that thermodynamic parameters of the aggregate cellular interaction remain constant over time, even perhaps as kinetic details of the molecular interactions vary to allow dynamic adhesion upon first encounter and stable adhesion later with reorientation.
Video microscopy of invasion shows that the RBC membrane undergoes substantial deformation during the primary, dynamic phase of adhesion [1, 2] . The optical tweezer-based study discussed above shows that perturbation of a stable merozoite-RBC interaction, which must involve rearrangement of individual molecular interactions between host and parasite, stimulates transient RBC membrane deformation [13 & ]. When considered with a fact that merozoites in these experiments were attached but could not invade RBCs, these observations are consistent with an intimate, likely causal link between merozoite-RBC adhesion and RBC membrane deformation. Based on theoretical constraints, 'wrapping' of the merozoite by a deformed RBC membrane, combined with the energy of adhesive interactions, was suggested to explain the tendency of a merozoite to reorient and attain stable attachment from first encounter [14] . Future studies might consider the use of drugs, or selected parasite or RBC variants to address the roles of the RBC membrane dynamics and host-parasite interactions in merozoite attachment.
Merozoite surface proteins (MSPs), present along the entire merozoite surface, are strong candidates for invasion ligands that mediate primary encounter with an RBC, either directly or indirectly [15] . Lin et al. [16] identified a functional complex of MSP1 with MSPDBL1 and MSPDBL2, both of which were shown to bind RBCs. In P. falciparum infections in Kenya, the presence of serum antibodies to MSPDBL2 is associated with protective effects from malaria [17] , supporting a study demonstrating strong selection on the gene [18] .
RBC ATTACHMENT THROUGH PARASITE RETICULOCYTE BINDING-LIKE AND ERYTHROCYTE BINDING-LIKE LIGANDS: FROM REDUNDANCY TO ESSENTIALITY
For Plasmodium species, the invasion ligands from the erythrocyte binding-like (EBL) and reticulocyte binding-like (RBL) families interact with specific RBC surface receptors to permit apical attachment following reorientation ( Fig. 1 ). EBL proteins contain DBL domains for receptor binding, whereas the determinants of RBC binding by RBL proteins have only recently begun to be elucidated (see below). Unlike MSPs, which are present constitutively all
KEY POINTS
The use of optical tweezers to interrogate Plasmodium merozoite-RBC attachment provides evidence that molecular interactions are optimized to provide uniformly strong adhesion through various phases of cellular interaction.
Whole-genome sequencing and protein biochemistry provide evidence that RBC interactions with RBL and EBL invasion ligands on the merozoite surface regulate the host species preference of Plasmodium parasites.
Anti-PfRh5 antibodies strongly inhibit RBC invasion; in the first such vaccine trial for PfRh5, immunization with PfRh5 antigens protects monkeys against P. falciparum. P. vivax requires the RBC receptor Duffy to invade RBCs, and new evidence that the parasite originated in Africa strongly suggests that the Duffy-negative RBC variant common today in ethnic Africans was historically relevant in human interactions with the parasite.
along the parasite surface, EBL and RBL proteins are stored in parasite micronemes and the anterior 'necks' of rhoptries prior to invasion. Near the time of invasion, their release at the apical end is related to increases in cellular calcium in the parasite [19, 20] . For Plasmodium and the distantly related parasite Toxoplasma gondii, an active topic of research has been the identification of parasite signal transduction molecules that regulate and respond to cellular calcium levels near the time of host cell invasion, reviewed in [21] .
Most RBL and EBL ligands have been shown to be individually dispensable for invasion by Plasmodium merozoites [8, 9] . Indeed, as antigens, it is thought that variant and compensatory expression of distinct but functionally redundant paralogs of invasion ligands could be a mechanism for the merozoite to evade the host immune system, reviewed in [22] . Nevertheless, because of their functional importance, researchers consider merozoite invasion ligands as targets for potential blood-stage vaccines for P. falciparum. To block RBC invasion by diverse strains of P. falciparum utilizing variable complements of invasion ligands, recent studies have explored combinations of EBL and P. falciparum RBL homolog (PfRh) antigens that might produce a broadly neutralizing vaccine [23] [24] [25] . 1 . An overview of red blood cell (RBC) invasion by Plasmodium merozoites. Following release into the bloodstream with rupture of an infected RBC, a merozoite encounters a new RBC and requires 1-2 min to complete re-invasion to establish a new round of the cell cycle. During encounter, the merozoite and the RBC undergo an ordered series of adhesive interactions, most of which are mediated by interaction of RBC receptors with parasite proteins, or invasion ligands, anchored to the merozoite plasma membrane surface.We depict nonoriented, primary adhesion (1), followed by apically oriented attachment (2), as described in the main text. We show P. falciparum invasion ligands that mediate apical attachment, and also the RBC receptor for a given ligand when known. The merozoite uses its own actin-based cytoskeletal machinery to drive intracellular entry (3) . At the outset of entry, the merozoite creates the tight junction (moving junction) with the RBC that seals the plasma membranes of the two cells. The tight junction acts as a foothold for the parasite as it enters the RBC and demarcates the nascent parasitophorous vacuole (PV) from the RBC membrane. Formation of the PV itself is stimulated by discharge of the rhoptry, which results in secretion of protein and lipid into the RBC following apical attachment. Invasion is completed when the PV, which will house the parasite through its ensuing development and replication, pinches off the from the RBC membrane into the host cytoplasm, with the vestige of the tight junction still apparent at the posterior (4). While most invaded parasites re-enter the asexual cell cycle for further parasite proliferation, a small fraction commit to gametocytogenesis, a developmental program for terminal sexual-stage differentiation that ensures parasite transmission.
RBC-invasion ligand interactions mediate host cell tropism for P. falciparum
In Plasmodium species, the specificity of RBL and EBL proteins for RBC receptors is thought to be a primary mechanism for host cell restriction in blood-stage parasites. Indeed, P. falciparum merozoites use the EBL ligands EBA-175 and EBA-140 to engage the RBC-specific receptors glycophorin A and glycophorin C, respectively, for RBC host invasion [8, 9] . In addition to tropism for RBCs, it has long been suspected that RBL and EBL invasion ligands govern host species preference (e.g. [26]), a view for which various recent studies provide support. Otto et al. [27 & ] performed whole-genome sequencing of the chimpanzee parasite P. reichenowi, and showed that the strongest regions of genetic divergence with human-specific P. falciparum include the loci for the EBL proteins and PfRh proteins. It is thus possible that diversification of these invasion ligands was a principal driving force for the varying host preference of these otherwise highly related parasite species.
In striking contrast to RBC interaction by many other RBL and EBL ligands, the interaction of PfRh5 with its receptor basigin is essential for P. falciparum invasion. The identification of the receptor-ligand pair was initially carried out by a biochemical approach designed to detect low-affinity interactions (AVEXIS), and further validated with in-vitro reverse genetic analysis of RBCs [28] . The same study showed that numerous, diverse strains of P. falciparum require the PfRh5-basigin interaction. Genetic studies show that PfRh5 can regulate the host species tropism of P. falciparum parasites [29, 30] , and biochemical studies provide evidence that species-specific polymorphisms in basigin influence binding by PfRh5. In assays with purified proteins, PfRh5 from P. falciparum displays a markedly stronger affinity for human basigin than for basigin orthologs from nonhominid great apes [31 & ]. Intriguingly, the same study identified a single 'humanizing' mutation in chimpanzee basigin sufficient to confer strong binding to PfRh5.
The determination of the co-crystal structure of PfRh5 with basigin provides for the first time structural insights into the function of any RBL protein [32 && ]. The flattened 'kite'-like architecture of PfRh5 comprised of two alpha-helical bundles is novel. PfRh5 makes contacts with basigin primarily along elements of the peptide backbone of the receptor, suggesting that to a degree, the complex could tolerate sequence polymorphisms in basigin that chiefly influence the amino acid side chain character of the protein. It is interesting to consider whether this feature of PfRh5-basigin might explain how P. falciparum has come to rely so heavily on the interaction for RBC invasion. As the authors show, the structure of the comparatively small PfRh5 protein facilitates prediction of plausible receptorbinding modules in considerably more complex and distantly related PfRh and RBL proteins from P. falciparum and other Plasmodium species, respectively. Presently, the receptor for only one other RBL protein is known; PfRh4 binds Complement Receptor 1 [33, 34] .
Invasion ligands as targets for vaccination against P. falciparum: all eyes on PfRh5
In recent years, PfRh5 has emerged as perhaps the most promising candidate antigen for a next-generation blood-stage vaccine. PfRh5 evades many of the challenges that confound other potential vaccine targets [22] . An essential function for PfRh5 ensures that P. falciparum parasites cannot circumvent its use for invasion. Additionally, PfRh5 is comparatively low in its sequence polymorphism, allowing specific anti-PfRh5 antibodies to potently inhibit RBC invasion by diverse strains of P. falciparum [35] [36] [37] [38] [39] .
Douglas et al. [40 && ] recently reported the results of the first anti-PfRh5 vaccine trial administered in Aotus nancymaae monkeys, which are animal models for P. falciparum infection. Although all animals in a control group developed high parasitemia that required drug treatment, most animals treated with PfRh5 vaccines were protected from such severe infection. Several monkeys vaccinated with a human compatible formulation self-cured. Anti-PfRh5 IgG levels in immunized animals were correlated with protection from P. falciparum, and antibodies inhibited growth of parasites in vitro. Recently, a shortpeptide epitope of PfRh5 was reported to elicit strong invasion-inhibitory antibodies following immunization [39] , a finding that may facilitate design of a future PfRh5-based vaccine.
Recently, it was reported that PfRh5 forms a functional complex with a glycophosphatidylinositol-linked extracellular protein, cysteine-rich protective antigen (CyRPA), thus providing an explanation for how the invasion ligand is anchored to the merozoite plasma membrane surface [10 && ]. The same study reported that like anti-PfRh5 antibodies, antibodies to CyRPA potently inhibit RBC invasion by diverse strains of P. falciparum, suggesting that CyRPA may also prove a promising vaccine target.
Duffy RBC receptor: a central (but not essential?) receptor for P. vivax
Experimental studies have shown that P. vivax relies strongly on the RBC receptor Duffy for invasion through an EBL family ligand, Duffy-binding protein (DBP). The erythroid-specific Duffy-negative mutation, also known as FyB ES , is common in ethnic sub-Saharan Africans and is credited for the highly diminished incidence of P. vivax in the continent [41] . In spite of the near absence of P. vivax in African people, Liu et al. [42 && ] detected comparatively diverse P. vivax and P. vivax-like parasites in wild Central African apes using a mitochondrial DNA sequencing-based approach. This finding establishes the African origin of P. vivax present in modern human populations, suggesting that the Duffy-negative RBC variant that prevails today in ethnic Africans was historically important in limiting spread of the parasitic infection.
Biochemical work on the interaction of P. vivax DBP with Duffy has also yielded basic insights about interaction of invasion ligands with RBC receptors. It had previously been shown that binding to Duffy drives the dimerization of DBP [43] . More recent work shows that the effect is reciprocal: dimerized DBP bound to a single binding domain from Duffy recruits an additional Duffy molecule into the complex with even higher affinity [44 & ]. Overall, this work reveals a stepwise, cooperative mode of binding, showing at the resolution of a single interaction between a parasite ligand and RBC receptor how Plasmodium merozoites can develop strong binding to their target cells.
Nevertheless, studies focusing on the centrality of Duffy to P. vivax invasion must contend with observations of P. vivax infections in Duffy-negative individuals in Madagascar [45] . Future work might consider alternative receptor-ligand interactions for P. vivax invasion, as has been described for P. falciparum [8, 9] .
NEW INSIGHTS ON AN RBC RECEPTOR-INDEPENDENT MODE OF HOST CELL ADHESION
For the Plasmodium invasion ligand apical membrane antigen (AMA)1, the parasite supplies its own receptor to allow the merozoite to engage the RBC membrane. The merozoite secretes the rhoptry neck (RON) complex of proteins into the host cell membrane, so that the RON2 subunit faces the parasite plasma membrane from the RBC surface for engagement with AMA1 [3, 46] . The AMA1-RON2 binding interaction is conserved in the distantly related parasite species T. gondii, indicating that these molecules are part of an ancient molecular strategy for host cell invasion that predates specific tropism for RBCs, reviewed in [47] .
The preponderance of evidence suggests that following apical reorientation, the AMA1-RON2 interaction is required for formation of the tight junction that allows the merozoite to efficiently enter the RBC [48, 49] . Yap et al. [50 & ] investigated the function of P. falciparum AMA1 by disrupting the endogenous gene during merozoite development. These researchers observed defects in tight junction formation by some merozoites, but likely owing to residual AMA1 protein, also an intermediate phenotype in a fraction of mutant merozoites attempting RBC invasion. As observed by video microscopy, some merozoites penetrated the RBC cytoplasmic space but could not seal and pinch off the parasitophorous vacuole membrane to complete invasion. The AMA1-RON2 interaction may thus help overcome energetic barriers associated with reconfiguration of plasma membrane topology for parasitophorous vacuole resealing, as well as at tight junction formation.
The AMA1 antigen has previously failed to elicit protection from P. falciparum in human vaccine trials [51] . Srinivasan et al. [52 && ] revisited the potential of AMA1 as a vaccine target in a mouse model, and made the remarkable finding that immunization with the recombinant extracellular domain of AMA1 specifically in complex with a RON2 peptide fragment provides sterile protection against P. yoelii. Despite extensive sequence polymorphism, a recent study proposes that for P. falciparum AMA1, a minimal combination of antigenic AMA1 alleles might produce antibodies that react with most natural variants of the target protein [53] .
RED BLOOD CELL AGE AND INVASION
P. falciparum merozoites invade and grow in RBCs of all ages, but blood-stage parasites of other species of Plasmodium are more restricted in their age preference. The selectivity of P. vivax for reticulocytes, which is a relatively transient stage in erythropoiesis, has made in-vitro culture of the parasite difficult. Using an ex-vivo assay with parasites drawn from patients, Malleret et al. [54 & ] showed that the selectivity of P. vivax for reticulocytes is at least partially explained by host cell invasion, demonstrating that invasion is restricted to very young reticulocytes still bearing the CD71 surface marker of erythroid precursors.
RBC age was also shown to be a factor for RBC invasion by P. knowlesi, which naturally infects rhesus monkeys but has become a significant source of human infection. In in-vitro lab cultures, the parasite weakly invades human RBCs, displaying a distinct preference for young cells. Nevertheless, extended culture of P. knowlesi with human RBCs allows parasites to adapt [55] [56] [57] , resulting in increased invasion of older RBCs and perhaps providing an explanation for unusually high parasitemia observed in some natural human infections by P. knowlesi [55] . From an experimental standpoint, P. knowlesi lines that proliferate in readily available human blood may expand the use of this comparatively genetically tractable parasite for in-vitro studies of Plasmodium biology, reviewed in [57] .
CONCLUSION AND FUTURE DIRECTIONS
How malaria merozoites selectively invade RBCs has been of long-standing interest in the malaria research community, and the recent work summarized here indicates substantial progress toward a cohesive, mechanistic explanation. Biophysical approaches like optical tweezers help clarify how molecular interactions between merozoites and RBCs give rise to the unique features of the cellular interaction. With continued development of tools for Plasmodium genetics and more recently RBC genetics [58] , tools like video microscopy will be key to measuring how specific parasite and host factors influence transient processes and cellular behaviors on a timescale relevant to invasion. Basic research on the function of invasion ligands has been particularly relevant to efforts to develop a blood-stage P. falciparum vaccine, for which there has been tangible progress, especially with regards to the PfRh5 and AMA1 antigens. Identification of previously unexplored, protective antigens indicates further avenues for development in this field [59] . In short, recent work on RBC invasion by Plasmodium merozoites has yielded many new insights regarding this unique parasitic behavior and is likely to advance efforts to treat malaria. The authors performed whole-genome sequencing of the chimpanzee parasite P. reichenowi, which shares a relatively recent common ancestry and high degree of genomic orthology with P. falciparum. The loci for the Rh and EBL ligands were among the genes that differed most strongly in sequence between the two parasite species, showing that these ligands could be principal determinants of host species preference. 
